Search research articles
Contact Us
Filters
Showing results (31-40 of 114) with videos related to
Page
of 12
Sort By:
Investigational New Drugs
|
August 25, 2000
A randomized trial comparing the nephrotoxicity of cisplatin/ifosfamide-based combination chemotherapy with or without amifostine in patients with solid tumors
J T Hartmann, L M Fels, S Knop, et al.
Anti-Cancer Drugs
|
September 7, 1999
Phase II study of oral trofosfamide as palliative therapy in pretreated patients with metastatic soft-tissue sarcoma
C Kollmannsberger, W Brugger, J T Hartmann, et al.
Anti-Cancer Drugs
|
November 26, 1999
Mitomycin C continuous infusion as salvage chemotherapy in pretreated patients with advanced gastric cancer
J T Hartmann, D Quietzsch, T Daikeler, et al.
Der Urologe. Ausg. A
|
September 17, 1998
[Register study for treatment of brain metastases of malignant testicular tumors]
J T Hartmann, P Albers, C Clemm, et al.
World Journal of Urology
|
March 23, 2004
The role of high-dose chemotherapy in relapsed germ cell tumors
O Rick, C Kollmannsberger, J T Hartmann, et al.
Anticancer Research
|
November 2, 2007
Management of late recurrence of a low-grade endometrial stromal sarcoma (LGESS): treatment with letrozole
K Krauss, C Bachmann, J T Hartmann, et al.
The Journal of Bone and Joint Surgery. British Volume
|
February 25, 2006
Multiple skeletal metastases from a giant cell tumour of the distal fibula with fatal outcome
C I Leichtle, U G Leichtle, V Gärtner, et al.
British Journal of Cancer
|
June 9, 1999
Long-term effects on sexual function and fertility after treatment of testicular cancer
J T Hartmann, C Albrecht, H J Schmoll, et al.
European Journal of Medical Research
|
July 2, 2011
Activity and side effects of imatinib in patients with gastrointestinal stromal tumors: data from a German multicenter trial
Marcus Schlemmer, S Bauer, R Schütte, et al.
Oncology
|
July 15, 1998
Is continuous 24-hour infusion of 5-fluorouracil plus high-dose folinic acid effective in patients with progressive or recurrent colorectal cancer? A phase II study
J T Hartmann, C H Köhne, H J Schmoll, et al.
Page
of 12
Search research articles
Search
Showing results (31-40 of 114) with videos related to
Sort By:
Page
of 12
Investigational New Drugs
|
August 25, 2000
A randomized trial comparing the nephrotoxicity of cisplatin/ifosfamide-based combination chemotherapy with or without amifostine in patients with solid tumors
J T Hartmann, L M Fels, S Knop, et al.
Anti-Cancer Drugs
|
September 7, 1999
Phase II study of oral trofosfamide as palliative therapy in pretreated patients with metastatic soft-tissue sarcoma
C Kollmannsberger, W Brugger, J T Hartmann, et al.
Anti-Cancer Drugs
|
November 26, 1999
Mitomycin C continuous infusion as salvage chemotherapy in pretreated patients with advanced gastric cancer
J T Hartmann, D Quietzsch, T Daikeler, et al.
Der Urologe. Ausg. A
|
September 17, 1998
[Register study for treatment of brain metastases of malignant testicular tumors]
J T Hartmann, P Albers, C Clemm, et al.
World Journal of Urology
|
March 23, 2004
The role of high-dose chemotherapy in relapsed germ cell tumors
O Rick, C Kollmannsberger, J T Hartmann, et al.
Anticancer Research
|
November 2, 2007
Management of late recurrence of a low-grade endometrial stromal sarcoma (LGESS): treatment with letrozole
K Krauss, C Bachmann, J T Hartmann, et al.
The Journal of Bone and Joint Surgery. British Volume
|
February 25, 2006
Multiple skeletal metastases from a giant cell tumour of the distal fibula with fatal outcome
C I Leichtle, U G Leichtle, V Gärtner, et al.
British Journal of Cancer
|
June 9, 1999
Long-term effects on sexual function and fertility after treatment of testicular cancer
J T Hartmann, C Albrecht, H J Schmoll, et al.
European Journal of Medical Research
|
July 2, 2011
Activity and side effects of imatinib in patients with gastrointestinal stromal tumors: data from a German multicenter trial
Marcus Schlemmer, S Bauer, R Schütte, et al.
Oncology
|
July 15, 1998
Is continuous 24-hour infusion of 5-fluorouracil plus high-dose folinic acid effective in patients with progressive or recurrent colorectal cancer? A phase II study
J T Hartmann, C H Köhne, H J Schmoll, et al.
Page
of 12